Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business

Velji brings more than 20 years of experience in biotech financial servicesBASEL, Switzerland--(BUSINESS WIRE)--Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointe...

Related Keywords

Switzerland ,San Francisco ,California ,United States ,Baylor College Of Medicine ,Texas ,Houston ,France ,Texas Medical Center ,French ,Opatrick Wilson ,Thomas Baumert ,Rizwan Velji ,William Blair ,Roberto Iacone ,Sariette Witte ,Northwestern University ,French National Institute Of Health ,Research Inserm ,Lazard ,Mcgill University ,University Of Strasbourg ,Alentis Therapeutics ,Chief Business Officer ,Chief Executive Officer ,Managing Director ,Healthcare Investment Banking ,Baylor College ,Human Physiology ,French National Institute ,Medical Research ,